Intuitive Surgical Up 10% on Q3 Earnings Beat

Trending News 🌥️

The company’s third quarter results for fiscal year 2022 were released today after the market close, and Intuitive Surgical ($NASDAQ:ISRG) stock is up 10% in post-market trading. Non-GAAP net income for the quarter came in at $429 million, beating expectations of $1.54 per share. This compares to the $439 million in non-GAAP net income recorded in the prior-year period. EPS for the quarter was $1.53, slightly higher than the $1.54 expected by analysts.

Intuitive Surgical attributed the beat to strong sales of the da Vinci Surgical System, as well as cost-cutting measures implemented during the pandemic. The company also announced a $1 billion share repurchase program.

Earnings

Intuitive Surgical Inc.’s stock is up 10% on the back of their latest quarterly earnings report which showed strong growth compared to the same period last year. This marks the third consecutive quarter of double-digit year-over-year revenue growth for ISRG, as the company continues to benefit from strong demand for its da Vinci surgical robots.

Price History

Intuitive Surgical, Inc. is a medical technology company that manufactures and markets robotic products used in minimally invasive surgery. On Tuesday, the company released its third quarter earnings results, which beat analyst expectations. As a result, the stock price increased by 1.9% on the day. So far, the media coverage of the earnings results has been mostly positive. Intuitive Surgical has been able to maintain its strong financial position and continue to invest in new products and technologies. Looking forward, Intuitive Surgical is well positioned to continue growing its business. The company’s strong financial position will allow it to continue investing in new products and technologies.

Additionally, the increasing demand for minimally invasive surgery is expected to drive growth for the company. Live Quote….

VI Analysis

Intuitive Surgical is a medical technology company that manufactures and markets minimally invasive surgical products and services. The company’s products include the da Vinci surgical system, which is a computer-assisted surgery platform that enables surgeons to perform complex procedures with minimally invasive techniques. Intuitive Surgical also offers a range of services to support its products, including training, maintenance, and repair services.

The company’s products are designed to improve patient outcomes and reduce surgical complications. Intuitive Surgical is a publicly traded company listed on the Nasdaq stock exchange.

VI Peers

The company’s da Vinci surgical system consists of a surgeon’s console, a patient-side cart and a vision system. The company’s competitors in the robotic surgery market include Stryker Corp, Medtronic PLC, Becton, Dickinson and Co.

– Stryker Corp ($NYSE:SYK)

With a market capitalization of $84.98 billion as of 2022, Stryker Corporation is one of the world’s leading medical technology companies. Headquartered in Kalamazoo, Michigan, the company offers a broad range of products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient care and quality of life. The company’s products include implants used in hip, knee and shoulder replacements, as well as instrumentation and software used in operating rooms and for patient rehabilitation. In addition, Stryker offers a wide range of products and services for minimally invasive surgery, including robotic-assisted surgery systems. The company’s return on equity was 10.79% as of 2022.

– Medtronic PLC ($NYSE:MDT)

Medtronic PLC is a medical technology company that develops and produces a variety of medical devices and software products. The company has a market capitalization of 112.31 billion as of 2022 and a return on equity of 7.49%. Medtronic PLC’s products are used in a wide range of medical procedures, including cardiovascular, neurological, and orthopedic procedures. The company’s products are sold in over 150 countries around the world.

– Becton, Dickinson and Co ($NYSE:BDX)

Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, laboratory equipment, and diagnostic products. The company has a market cap of 64.37B as of 2022 and a return on equity of 6.42%. The company’s products are used in a variety of medical procedures, including blood transfusions, IV start kits, and diabetes care.

Summary

Intuitive Surgical is a medical technology company that manufactures and markets robotic surgical systems. The company’s products are used in a variety of surgical procedures, including general surgery, gynecology, urology and cardiac surgery. ISRG has a history of strong financial performance, with revenue and earnings growing at a double-digit pace in recent years. Investors have been attracted to ISRG by its strong growth prospects.

The company is also investing heavily in R&D, with a focus on developing new applications for its technology. Given its strong growth prospects and market-leading position, ISRG is a compelling investment option for growth-oriented investors.